Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.62295006 |
2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.62295006 |
3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.39824616 |
4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.76160750 |
5 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.67554598 |
6 | leukocyte aggregation (GO:0070486) | 3.38561951 |
7 | negative T cell selection (GO:0043383) | 3.36131540 |
8 | ribosomal small subunit assembly (GO:0000028) | 3.33311190 |
9 | negative thymic T cell selection (GO:0045060) | 3.33291038 |
10 | cytidine deamination (GO:0009972) | 3.21537304 |
11 | cytidine metabolic process (GO:0046087) | 3.21537304 |
12 | cytidine catabolic process (GO:0006216) | 3.21537304 |
13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.19045543 |
14 | negative regulation of cell killing (GO:0031342) | 3.15695293 |
15 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.15695293 |
16 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.07729589 |
17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.05164610 |
18 | granulocyte activation (GO:0036230) | 2.98132529 |
19 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.95904734 |
20 | negative regulation of interleukin-12 production (GO:0032695) | 2.93446261 |
21 | leukocyte degranulation (GO:0043299) | 2.92693456 |
22 | myeloid cell activation involved in immune response (GO:0002275) | 2.92690992 |
23 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.90409698 |
24 | viral transcription (GO:0019083) | 2.89233118 |
25 | interferon-gamma production (GO:0032609) | 2.87445743 |
26 | thrombin receptor signaling pathway (GO:0070493) | 2.87284666 |
27 | mast cell activation (GO:0045576) | 2.87023243 |
28 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.86679926 |
29 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.86679926 |
30 | modulation by symbiont of host immune response (GO:0052553) | 2.86679926 |
31 | positive regulation by symbiont of host defense response (GO:0052509) | 2.86679926 |
32 | modulation by symbiont of host defense response (GO:0052031) | 2.86679926 |
33 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.86679926 |
34 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.86118616 |
35 | regulation of regulatory T cell differentiation (GO:0045589) | 2.85181660 |
36 | translational termination (GO:0006415) | 2.80446255 |
37 | immunoglobulin mediated immune response (GO:0016064) | 2.79173818 |
38 | negative regulation of phagocytosis (GO:0050765) | 2.78189938 |
39 | neutrophil activation involved in immune response (GO:0002283) | 2.77236547 |
40 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.75649658 |
41 | hepatocyte apoptotic process (GO:0097284) | 2.72858562 |
42 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.72127599 |
43 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.72089949 |
44 | regulation of gamma-delta T cell activation (GO:0046643) | 2.71994249 |
45 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.70921464 |
46 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.70227180 |
47 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.69710298 |
48 | positive regulation of interferon-alpha production (GO:0032727) | 2.68816347 |
49 | ribosomal small subunit biogenesis (GO:0042274) | 2.67857636 |
50 | positive T cell selection (GO:0043368) | 2.67546291 |
51 | detection of bacterium (GO:0016045) | 2.67441651 |
52 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.66659771 |
53 | mature B cell differentiation involved in immune response (GO:0002313) | 2.66383304 |
54 | negative regulation of B cell apoptotic process (GO:0002903) | 2.65555972 |
55 | T cell migration (GO:0072678) | 2.65106821 |
56 | cellular response to interferon-beta (GO:0035458) | 2.64567994 |
57 | regulation of B cell apoptotic process (GO:0002902) | 2.64235264 |
58 | B cell mediated immunity (GO:0019724) | 2.64190864 |
59 | protein targeting to ER (GO:0045047) | 2.63874442 |
60 | cotranslational protein targeting to membrane (GO:0006613) | 2.63186772 |
61 | positive thymic T cell selection (GO:0045059) | 2.62835780 |
62 | detection of other organism (GO:0098543) | 2.62692910 |
63 | regulation of mast cell degranulation (GO:0043304) | 2.62541082 |
64 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.62083417 |
65 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.59506347 |
66 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.59019826 |
67 | actin nucleation (GO:0045010) | 2.58648222 |
68 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.57977621 |
69 | regulation of interferon-alpha production (GO:0032647) | 2.57548001 |
70 | regulation of B cell differentiation (GO:0045577) | 2.55484480 |
71 | positive regulation of B cell differentiation (GO:0045579) | 2.55066006 |
72 | NIK/NF-kappaB signaling (GO:0038061) | 2.54722538 |
73 | sequestering of actin monomers (GO:0042989) | 2.51757554 |
74 | protein localization to endoplasmic reticulum (GO:0070972) | 2.49690983 |
75 | defense response to protozoan (GO:0042832) | 2.49328477 |
76 | thymic T cell selection (GO:0045061) | 2.48414690 |
77 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.47971509 |
78 | positive regulation of granulocyte differentiation (GO:0030854) | 2.45343126 |
79 | translational elongation (GO:0006414) | 2.44568496 |
80 | negative regulation of T cell apoptotic process (GO:0070233) | 2.44507182 |
81 | positive regulation of mast cell activation (GO:0033005) | 2.44132255 |
82 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.44129537 |
83 | positive regulation of macrophage differentiation (GO:0045651) | 2.43970374 |
84 | negative regulation of leukocyte apoptotic process (GO:2000107) | 2.43719881 |
85 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.43536612 |
86 | response to interferon-beta (GO:0035456) | 2.43479369 |
87 | regulation of mast cell activation (GO:0033003) | 2.43374125 |
88 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.43330154 |
89 | regulation of response to interferon-gamma (GO:0060330) | 2.41262704 |
90 | positive regulation of isotype switching (GO:0045830) | 2.41166866 |
91 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.41125818 |
92 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.40674478 |
93 | response to type I interferon (GO:0034340) | 2.40231606 |
94 | positive regulation of defense response to virus by host (GO:0002230) | 2.39063421 |
95 | type I interferon signaling pathway (GO:0060337) | 2.39057189 |
96 | cellular response to type I interferon (GO:0071357) | 2.39057189 |
97 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.38607310 |
98 | response to peptidoglycan (GO:0032494) | 2.38041664 |
99 | respiratory burst (GO:0045730) | 2.37406393 |
100 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.36572307 |
101 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.35227028 |
102 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.34645639 |
103 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.33559693 |
104 | negative regulation of viral genome replication (GO:0045071) | 2.33495983 |
105 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.33088648 |
106 | viral life cycle (GO:0019058) | 2.32943014 |
107 | regulation of T cell tolerance induction (GO:0002664) | 2.32940702 |
108 | positive regulation of antigen processing and presentation (GO:0002579) | 2.30400072 |
109 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.29326009 |
110 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.28109538 |
111 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.26508239 |
112 | regulation of antigen processing and presentation (GO:0002577) | 2.25961038 |
113 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.25499641 |
114 | T cell selection (GO:0045058) | 2.22730533 |
115 | positive regulation of interleukin-2 production (GO:0032743) | 2.22178204 |
116 | neutrophil activation (GO:0042119) | 2.21926557 |
117 | myeloid dendritic cell activation (GO:0001773) | 2.21844103 |
118 | response to interleukin-15 (GO:0070672) | 2.21533926 |
119 | tolerance induction (GO:0002507) | 2.21517830 |
120 | pinocytosis (GO:0006907) | 2.19138686 |
121 | ribosomal large subunit biogenesis (GO:0042273) | 2.19065350 |
122 | translational initiation (GO:0006413) | 2.18463157 |
123 | DNA strand elongation (GO:0022616) | 2.18170317 |
124 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.17557013 |
125 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.17415768 |
126 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.16940580 |
127 | cellular response to interleukin-15 (GO:0071350) | 2.16724029 |
128 | signal peptide processing (GO:0006465) | 2.16288071 |
129 | DNA deamination (GO:0045006) | 2.15648890 |
130 | maturation of SSU-rRNA (GO:0030490) | 2.15348814 |
131 | leukocyte cell-cell adhesion (GO:0007159) | 2.14407232 |
132 | B cell receptor signaling pathway (GO:0050853) | 2.14102814 |
133 | T cell apoptotic process (GO:0070231) | 2.13011679 |
134 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.12413277 |
135 | positive regulation of B cell mediated immunity (GO:0002714) | 2.12413277 |
136 | telomere maintenance via recombination (GO:0000722) | 2.11837088 |
137 | T cell costimulation (GO:0031295) | 2.11273151 |
138 | cellular protein complex disassembly (GO:0043624) | 2.10895460 |
139 | natural killer cell mediated immunity (GO:0002228) | 2.10541383 |
140 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.10541383 |
141 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.09578592 |
142 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.09093942 |
143 | lymphocyte costimulation (GO:0031294) | 2.09051217 |
144 | cellular response to exogenous dsRNA (GO:0071360) | 2.08631162 |
145 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.08425659 |
146 | response to protozoan (GO:0001562) | 2.07989296 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.04437602 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.60653689 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.94030812 |
4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.92262636 |
5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.91798453 |
6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.83642183 |
7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.82779979 |
8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.55800837 |
9 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.37109277 |
10 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.31622295 |
11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.25031522 |
12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.23305778 |
13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.22332168 |
14 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.14276286 |
15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.10153651 |
16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.09884342 |
17 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.09214017 |
18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.03145337 |
19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.03092035 |
20 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.96894106 |
21 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.95465191 |
22 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.93345102 |
23 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.88538417 |
24 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.86094976 |
25 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.80824201 |
26 | * FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.80707914 |
27 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.80404464 |
28 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.78708363 |
29 | * MYC_22102868_ChIP-Seq_BL_Human | 1.75135998 |
30 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.74856097 |
31 | MYB_26560356_Chip-Seq_TH2_Human | 1.74679417 |
32 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.73942758 |
33 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.70346542 |
34 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.68105578 |
35 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67622735 |
36 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67609582 |
37 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.66213911 |
38 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.65178109 |
39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.64835313 |
40 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.63475233 |
41 | MAF_26560356_Chip-Seq_TH1_Human | 1.62454188 |
42 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.61740779 |
43 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59186388 |
44 | MYB_26560356_Chip-Seq_TH1_Human | 1.58586005 |
45 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.58364687 |
46 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.57089825 |
47 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.56381513 |
48 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.56320894 |
49 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54020503 |
50 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.53899230 |
51 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.51106596 |
52 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.50780139 |
53 | SPI1_23127762_ChIP-Seq_K562_Human | 1.48984034 |
54 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.47609515 |
55 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.45902026 |
56 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.44590337 |
57 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.44456132 |
58 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.44244943 |
59 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.43538457 |
60 | UTX_26944678_Chip-Seq_JUKART_Human | 1.41625656 |
61 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.41207834 |
62 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.39614701 |
63 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.38207026 |
64 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.37582870 |
65 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35967355 |
66 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.35775657 |
67 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.33958203 |
68 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.32021186 |
69 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.27430172 |
70 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.26073627 |
71 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25902813 |
72 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.24985175 |
73 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.23836539 |
74 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.23592742 |
75 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.23020139 |
76 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.22583634 |
77 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20407233 |
78 | GATA3_26560356_Chip-Seq_TH2_Human | 1.20003854 |
79 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.19420745 |
80 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19045205 |
81 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.16669334 |
82 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.14695234 |
83 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.14641800 |
84 | MAF_26560356_Chip-Seq_TH2_Human | 1.14229050 |
85 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.11920346 |
86 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11901004 |
87 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.10068913 |
88 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.09088053 |
89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08423792 |
90 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.06084262 |
91 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.05378837 |
92 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05278908 |
93 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05023403 |
94 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.04212973 |
95 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03997677 |
96 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.03205812 |
97 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.02949080 |
98 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.02696293 |
99 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.02596207 |
100 | GATA1_22025678_ChIP-Seq_K562_Human | 1.02214935 |
101 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.02144683 |
102 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.02127054 |
103 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.02083493 |
104 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02055950 |
105 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.01212836 |
106 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.01191944 |
107 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00903254 |
108 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00521210 |
109 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.00402682 |
110 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99446603 |
111 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99052245 |
112 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.97992133 |
113 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.97867308 |
114 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.97112621 |
115 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.96907907 |
116 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95890095 |
117 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95791466 |
118 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.94471495 |
119 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.94202066 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.46719376 |
2 | MP0005671_abnormal_response_to | 2.83390393 |
3 | MP0009785_altered_susceptibility_to | 2.70106175 |
4 | MP0000685_abnormal_immune_system | 2.58602330 |
5 | MP0003436_decreased_susceptibility_to | 2.56743571 |
6 | MP0001800_abnormal_humoral_immune | 2.44248247 |
7 | MP0003763_abnormal_thymus_physiology | 2.42607231 |
8 | MP0001790_abnormal_immune_system | 2.32493926 |
9 | MP0005387_immune_system_phenotype | 2.32493926 |
10 | MP0005000_abnormal_immune_tolerance | 2.30973624 |
11 | MP0002452_abnormal_antigen_presenting | 2.26341004 |
12 | MP0002148_abnormal_hypersensitivity_rea | 2.24291530 |
13 | MP0005025_abnormal_response_to | 2.23743267 |
14 | MP0009333_abnormal_splenocyte_physiolog | 2.16547641 |
15 | MP0002723_abnormal_immune_serum | 2.16010678 |
16 | MP0003724_increased_susceptibility_to | 2.14333065 |
17 | MP0002420_abnormal_adaptive_immunity | 2.11920601 |
18 | MP0001819_abnormal_immune_cell | 2.11369857 |
19 | MP0006082_CNS_inflammation | 2.09176765 |
20 | MP0002419_abnormal_innate_immunity | 2.07121918 |
21 | MP0003693_abnormal_embryo_hatching | 1.94805538 |
22 | MP0002398_abnormal_bone_marrow | 1.91302629 |
23 | MP0009840_abnormal_foam_cell | 1.89954983 |
24 | MP0002405_respiratory_system_inflammati | 1.89138071 |
25 | MP0002166_altered_tumor_susceptibility | 1.85859517 |
26 | MP0010155_abnormal_intestine_physiology | 1.81535011 |
27 | MP0000716_abnormal_immune_system | 1.77740109 |
28 | MP0000689_abnormal_spleen_morphology | 1.70382963 |
29 | MP0002396_abnormal_hematopoietic_system | 1.69362583 |
30 | MP0001873_stomach_inflammation | 1.69019781 |
31 | MP0002722_abnormal_immune_system | 1.66760541 |
32 | MP0005360_urolithiasis | 1.64699426 |
33 | MP0004947_skin_inflammation | 1.63797822 |
34 | MP0001845_abnormal_inflammatory_respons | 1.62370750 |
35 | MP0002006_tumorigenesis | 1.60142107 |
36 | MP0005464_abnormal_platelet_physiology | 1.59272324 |
37 | MP0005451_abnormal_body_composition | 1.58012600 |
38 | MP0002429_abnormal_blood_cell | 1.57918059 |
39 | MP0001853_heart_inflammation | 1.56738375 |
40 | MP0003303_peritoneal_inflammation | 1.53708258 |
41 | MP0000858_altered_metastatic_potential | 1.47358799 |
42 | MP0000490_abnormal_crypts_of | 1.46484507 |
43 | MP0002138_abnormal_hepatobiliary_system | 1.44102643 |
44 | MP0003806_abnormal_nucleotide_metabolis | 1.43874569 |
45 | MP0008469_abnormal_protein_level | 1.43633789 |
46 | MP0010352_gastrointestinal_tract_polyps | 1.41923970 |
47 | MP0004957_abnormal_blastocyst_morpholog | 1.35932521 |
48 | MP0001533_abnormal_skeleton_physiology | 1.34089129 |
49 | MP0000703_abnormal_thymus_morphology | 1.32147995 |
50 | MP0002933_joint_inflammation | 1.31824879 |
51 | MP0008007_abnormal_cellular_replicative | 1.31702841 |
52 | MP0003077_abnormal_cell_cycle | 1.30664034 |
53 | MP0002139_abnormal_hepatobiliary_system | 1.29720549 |
54 | MP0003300_gastrointestinal_ulcer | 1.28183951 |
55 | MP0006054_spinal_hemorrhage | 1.25094461 |
56 | MP0002132_abnormal_respiratory_system | 1.25047054 |
57 | MP0008260_abnormal_autophagy | 1.21901877 |
58 | MP0003186_abnormal_redox_activity | 1.21067521 |
59 | MP0003448_altered_tumor_morphology | 1.18823939 |
60 | MP0001545_abnormal_hematopoietic_system | 1.18566995 |
61 | MP0005397_hematopoietic_system_phenotyp | 1.18566995 |
62 | MP0008057_abnormal_DNA_replication | 1.14924925 |
63 | MP0000465_gastrointestinal_hemorrhage | 1.14672461 |
64 | MP0003191_abnormal_cellular_cholesterol | 1.13703307 |
65 | * MP0003866_abnormal_defecation | 1.13695123 |
66 | MP0009764_decreased_sensitivity_to | 1.12826006 |
67 | * MP0005058_abnormal_lysosome_morphology | 1.12564494 |
68 | MP0003075_altered_response_to | 1.12095433 |
69 | MP0002019_abnormal_tumor_incidence | 1.08832604 |
70 | MP0010094_abnormal_chromosome_stability | 1.08737752 |
71 | MP0003111_abnormal_nucleus_morphology | 1.05462749 |
72 | MP0005166_decreased_susceptibility_to | 1.05402313 |
73 | MP0005310_abnormal_salivary_gland | 1.04453893 |
74 | MP0001851_eye_inflammation | 1.00731522 |
75 | MP0005023_abnormal_wound_healing | 0.98107802 |
76 | MP0008004_abnormal_stomach_pH | 0.97019372 |
77 | MP0004808_abnormal_hematopoietic_stem | 0.96236104 |
78 | MP0005365_abnormal_bile_salt | 0.95143033 |
79 | MP0003183_abnormal_peptide_metabolism | 0.92947218 |
80 | MP0003172_abnormal_lysosome_physiology | 0.91878316 |
81 | MP0001663_abnormal_digestive_system | 0.91071071 |
82 | MP0000609_abnormal_liver_physiology | 0.90271517 |
83 | MP0003786_premature_aging | 0.88898961 |
84 | MP0002877_abnormal_melanocyte_morpholog | 0.87661011 |
85 | MP0004782_abnormal_surfactant_physiolog | 0.87278853 |
86 | MP0008058_abnormal_DNA_repair | 0.86821470 |
87 | MP0009643_abnormal_urine_homeostasis | 0.85860995 |
88 | MP0009763_increased_sensitivity_to | 0.84682630 |
89 | MP0005084_abnormal_gallbladder_morpholo | 0.84082430 |
90 | MP0000015_abnormal_ear_pigmentation | 0.83211603 |
91 | MP0006036_abnormal_mitochondrial_physio | 0.82419662 |
92 | MP0002136_abnormal_kidney_physiology | 0.82409918 |
93 | MP0003566_abnormal_cell_adhesion | 0.81835037 |
94 | MP0009278_abnormal_bone_marrow | 0.81399771 |
95 | MP0005075_abnormal_melanosome_morpholog | 0.81394156 |
96 | MP0003656_abnormal_erythrocyte_physiolo | 0.81274985 |
97 | MP0001243_abnormal_dermal_layer | 0.81122778 |
98 | MP0003453_abnormal_keratinocyte_physiol | 0.80869723 |
99 | MP0000598_abnormal_liver_morphology | 0.80092704 |
100 | MP0005408_hypopigmentation | 0.79409829 |
101 | MP0000343_altered_response_to | 0.79212598 |
102 | MP0002998_abnormal_bone_remodeling | 0.78101546 |
103 | MP0005085_abnormal_gallbladder_physiolo | 0.78006343 |
104 | MP0004019_abnormal_vitamin_homeostasis | 0.77372679 |
105 | MP0001764_abnormal_homeostasis | 0.76688654 |
106 | MP0010307_abnormal_tumor_latency | 0.74900730 |
107 | * MP0000477_abnormal_intestine_morphology | 0.72488799 |
108 | MP0008875_abnormal_xenobiotic_pharmacok | 0.72307492 |
109 | MP0009697_abnormal_copulation | 0.71668145 |
110 | MP0005165_increased_susceptibility_to | 0.71431498 |
111 | MP0005319_abnormal_enzyme/_coenzyme | 0.70774150 |
112 | * MP0001666_abnormal_nutrient_absorption | 0.70314970 |
113 | MP0005076_abnormal_cell_differentiation | 0.69868167 |
114 | MP0000249_abnormal_blood_vessel | 0.68907384 |
115 | MP0004883_abnormal_blood_vessel | 0.68573919 |
116 | MP0008932_abnormal_embryonic_tissue | 0.68243899 |
117 | MP0009765_abnormal_xenobiotic_induced | 0.67135822 |
118 | MP0003828_pulmonary_edema | 0.67043153 |
119 | MP0008873_increased_physiological_sensi | 0.66860547 |
120 | MP0000313_abnormal_cell_death | 0.66752567 |
121 | MP0005083_abnormal_biliary_tract | 0.66133641 |
122 | MP0005164_abnormal_response_to | 0.64738133 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Prolonged bleeding time (HP:0003010) | 4.49970784 |
2 | Eczematoid dermatitis (HP:0000976) | 4.05376419 |
3 | Recurrent abscess formation (HP:0002722) | 3.95415833 |
4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.77297049 |
5 | IgM deficiency (HP:0002850) | 3.61282671 |
6 | Abnormality of T cell number (HP:0011839) | 3.53986702 |
7 | T lymphocytopenia (HP:0005403) | 3.46728293 |
8 | Recurrent bacterial skin infections (HP:0005406) | 3.39992416 |
9 | Chronic otitis media (HP:0000389) | 3.34527548 |
10 | Recurrent viral infections (HP:0004429) | 3.32852458 |
11 | Increased mean platelet volume (HP:0011877) | 3.30292925 |
12 | Recurrent fungal infections (HP:0002841) | 3.22972163 |
13 | Abnormality of T cells (HP:0002843) | 3.22857293 |
14 | Combined immunodeficiency (HP:0005387) | 3.16163637 |
15 | Myositis (HP:0100614) | 3.11576419 |
16 | Severe combined immunodeficiency (HP:0004430) | 3.08072549 |
17 | Autoimmune thrombocytopenia (HP:0001973) | 3.07813028 |
18 | Menorrhagia (HP:0000132) | 3.07697096 |
19 | Petechiae (HP:0000967) | 3.03362712 |
20 | Vacuolated lymphocytes (HP:0001922) | 3.01969560 |
21 | Abnormality of T cell physiology (HP:0011840) | 3.00261392 |
22 | Recurrent bronchitis (HP:0002837) | 2.98936577 |
23 | Pustule (HP:0200039) | 2.93427151 |
24 | Granulocytopenia (HP:0001913) | 2.89077470 |
25 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.88951699 |
26 | Abnormality of macrophages (HP:0004311) | 2.85617188 |
27 | Eosinophilia (HP:0001880) | 2.84540006 |
28 | Thrombocytosis (HP:0001894) | 2.82431532 |
29 | IgG deficiency (HP:0004315) | 2.78431943 |
30 | Impaired platelet aggregation (HP:0003540) | 2.76321466 |
31 | Abnormal platelet function (HP:0011869) | 2.76321466 |
32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.75802342 |
33 | Abnormality of eosinophils (HP:0001879) | 2.68562103 |
34 | Recurrent skin infections (HP:0001581) | 2.66271460 |
35 | Chest pain (HP:0100749) | 2.60716732 |
36 | Panhypogammaglobulinemia (HP:0003139) | 2.60539095 |
37 | Aplastic anemia (HP:0001915) | 2.56012338 |
38 | Meningitis (HP:0001287) | 2.54744200 |
39 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.53541347 |
40 | Increased IgM level (HP:0003496) | 2.52783473 |
41 | Leukocytosis (HP:0001974) | 2.50808093 |
42 | Increased IgE level (HP:0003212) | 2.50416504 |
43 | Recurrent cutaneous fungal infections (HP:0011370) | 2.50041654 |
44 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.50041654 |
45 | Lymphopenia (HP:0001888) | 2.49150575 |
46 | Increased serum ferritin (HP:0003281) | 2.47394116 |
47 | Stomatitis (HP:0010280) | 2.46689158 |
48 | Mediastinal lymphadenopathy (HP:0100721) | 2.42704433 |
49 | Vasculitis (HP:0002633) | 2.42345388 |
50 | Obstructive lung disease (HP:0006536) | 2.41495355 |
51 | Chronic obstructive pulmonary disease (HP:0006510) | 2.41495355 |
52 | Encephalitis (HP:0002383) | 2.40833647 |
53 | Nasal polyposis (HP:0100582) | 2.40125793 |
54 | Orchitis (HP:0100796) | 2.36002792 |
55 | Spontaneous hematomas (HP:0007420) | 2.35409019 |
56 | Thyroiditis (HP:0100646) | 2.34779334 |
57 | Hypertensive crisis (HP:0100735) | 2.33987589 |
58 | Acute hepatic failure (HP:0006554) | 2.33788957 |
59 | Reticulocytopenia (HP:0001896) | 2.33663386 |
60 | Chronic diarrhea (HP:0002028) | 2.30060913 |
61 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.29678702 |
62 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.29678702 |
63 | Abnormality of glycolipid metabolism (HP:0010969) | 2.29678702 |
64 | Abnormality of iron homeostasis (HP:0011031) | 2.27708478 |
65 | Agammaglobulinemia (HP:0004432) | 2.26696771 |
66 | Optic neuritis (HP:0100653) | 2.23095919 |
67 | Retrobulbar optic neuritis (HP:0100654) | 2.23095919 |
68 | Abnormality of B cell number (HP:0010975) | 2.21505696 |
69 | B lymphocytopenia (HP:0010976) | 2.21505696 |
70 | Interstitial pulmonary disease (HP:0006530) | 2.21428232 |
71 | Periodontitis (HP:0000704) | 2.17092174 |
72 | Joint swelling (HP:0001386) | 2.15522220 |
73 | Cellulitis (HP:0100658) | 2.14948273 |
74 | IgA deficiency (HP:0002720) | 2.14820582 |
75 | Hemoptysis (HP:0002105) | 2.09372861 |
76 | Abnormality of the nasal mucosa (HP:0000433) | 2.08316031 |
77 | Recurrent sinusitis (HP:0011108) | 2.07206987 |
78 | Gingival bleeding (HP:0000225) | 2.06094972 |
79 | Hypergammaglobulinemia (HP:0010702) | 2.05983552 |
80 | Purpura (HP:0000979) | 2.04734818 |
81 | Inflammation of the large intestine (HP:0002037) | 2.03582479 |
82 | Keratoconjunctivitis sicca (HP:0001097) | 2.03552643 |
83 | Lymphoma (HP:0002665) | 2.03310657 |
84 | Gastrointestinal inflammation (HP:0004386) | 2.02906675 |
85 | Gangrene (HP:0100758) | 2.02619005 |
86 | Autoimmune hemolytic anemia (HP:0001890) | 2.02603121 |
87 | Urticaria (HP:0001025) | 2.02115606 |
88 | Nonimmune hydrops fetalis (HP:0001790) | 2.00057487 |
89 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.99932194 |
90 | Hypobetalipoproteinemia (HP:0003563) | 1.99107518 |
91 | Systemic lupus erythematosus (HP:0002725) | 1.96838927 |
92 | Gingivitis (HP:0000230) | 1.95971393 |
93 | Hypoplasia of the thymus (HP:0000778) | 1.93937921 |
94 | Poor head control (HP:0002421) | 1.93463563 |
95 | Abnormality of the pleura (HP:0002103) | 1.93245896 |
96 | Prostate neoplasm (HP:0100787) | 1.93109903 |
97 | Epistaxis (HP:0000421) | 1.92900414 |
98 | Pancytopenia (HP:0001876) | 1.92884812 |
99 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.91401537 |
100 | Abnormal platelet volume (HP:0011876) | 1.91293462 |
101 | Hepatosplenomegaly (HP:0001433) | 1.91023945 |
102 | Pulmonary infiltrates (HP:0002113) | 1.89936484 |
103 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.89500767 |
104 | Macrocytic anemia (HP:0001972) | 1.89278319 |
105 | Anorexia (HP:0002039) | 1.89048668 |
106 | Skin ulcer (HP:0200042) | 1.88710094 |
107 | Birth length less than 3rd percentile (HP:0003561) | 1.88684938 |
108 | Arterial thrombosis (HP:0004420) | 1.88463014 |
109 | Fatigue (HP:0012378) | 1.86982816 |
110 | Glomerulopathy (HP:0100820) | 1.86034393 |
111 | Thrombophlebitis (HP:0004418) | 1.85734018 |
112 | Abnormality of the prostate (HP:0008775) | 1.85088047 |
113 | Basal ganglia calcification (HP:0002135) | 1.82031017 |
114 | Gastrointestinal infarctions (HP:0005244) | 1.81785322 |
115 | Osteomyelitis (HP:0002754) | 1.80225883 |
116 | Abnormal number of erythroid precursors (HP:0012131) | 1.79973905 |
117 | Amaurosis fugax (HP:0100576) | 1.79396372 |
118 | Neutropenia (HP:0001875) | 1.79106154 |
119 | Recurrent pneumonia (HP:0006532) | 1.77914450 |
120 | Skin rash (HP:0000988) | 1.76244656 |
121 | Colitis (HP:0002583) | 1.74752464 |
122 | Joint hemorrhage (HP:0005261) | 1.72872005 |
123 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.71675313 |
124 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.71526983 |
125 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.71252671 |
126 | Reduced antithrombin III activity (HP:0001976) | 1.71086802 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 3.69795304 |
2 | VRK2 | 3.61173712 |
3 | RIPK4 | 3.04038362 |
4 | TXK | 2.73853010 |
5 | BUB1 | 2.63655283 |
6 | BLK | 2.59967739 |
7 | TYK2 | 2.41471096 |
8 | TESK2 | 2.35409001 |
9 | IRAK4 | 2.25615858 |
10 | EIF2AK1 | 2.20694697 |
11 | STK10 | 2.13153731 |
12 | TBK1 | 2.12294378 |
13 | MAP3K14 | 2.07065306 |
14 | NME2 | 2.02439399 |
15 | IRAK3 | 2.02008749 |
16 | JAK3 | 2.00581857 |
17 | MST4 | 1.96963764 |
18 | ZAP70 | 1.94835887 |
19 | IKBKE | 1.84909323 |
20 | FES | 1.83499621 |
21 | KDR | 1.76420149 |
22 | SCYL2 | 1.74490220 |
23 | TEC | 1.71489691 |
24 | PIM2 | 1.64224447 |
25 | IKBKB | 1.63156892 |
26 | ITK | 1.62033627 |
27 | SMG1 | 1.57172611 |
28 | BTK | 1.56801672 |
29 | GRK6 | 1.55939482 |
30 | TAOK3 | 1.55167730 |
31 | TLK1 | 1.53600391 |
32 | KIT | 1.53130477 |
33 | FGFR4 | 1.49883836 |
34 | RPS6KA4 | 1.47196730 |
35 | EIF2AK3 | 1.39036536 |
36 | ERN1 | 1.35673010 |
37 | PIM1 | 1.30894637 |
38 | LRRK2 | 1.30458354 |
39 | CSF1R | 1.27211197 |
40 | TESK1 | 1.26862830 |
41 | CSK | 1.24811802 |
42 | BMPR2 | 1.16882511 |
43 | JAK1 | 1.14873919 |
44 | SYK | 1.14495102 |
45 | PBK | 1.11564861 |
46 | PASK | 1.10981170 |
47 | LCK | 1.10335072 |
48 | TAOK2 | 1.08148951 |
49 | NEK9 | 1.07962715 |
50 | CLK1 | 1.07832386 |
51 | WEE1 | 1.06559221 |
52 | MAP3K10 | 1.05565531 |
53 | TSSK6 | 1.05491896 |
54 | NLK | 1.00680639 |
55 | STK4 | 1.00481309 |
56 | CHUK | 0.99229544 |
57 | LYN | 0.97783110 |
58 | PLK4 | 0.96802274 |
59 | MATK | 0.96668202 |
60 | STK16 | 0.95644753 |
61 | DAPK1 | 0.95495566 |
62 | VRK1 | 0.93660415 |
63 | SRPK1 | 0.93358661 |
64 | FLT3 | 0.92797051 |
65 | PRPF4B | 0.92040469 |
66 | NEK2 | 0.89858936 |
67 | TGFBR1 | 0.88040926 |
68 | ACVR1B | 0.86634009 |
69 | EPHB1 | 0.85943953 |
70 | RPS6KB2 | 0.84873655 |
71 | SIK3 | 0.83623542 |
72 | FGR | 0.79984319 |
73 | TNK2 | 0.77283463 |
74 | PAK4 | 0.76584681 |
75 | MAP3K8 | 0.76017968 |
76 | BRSK2 | 0.74970136 |
77 | EIF2AK2 | 0.74724780 |
78 | PIK3CG | 0.72451819 |
79 | MAP2K3 | 0.66386775 |
80 | MAP3K12 | 0.66348359 |
81 | MAP3K11 | 0.65691440 |
82 | HCK | 0.65528964 |
83 | TGFBR2 | 0.64924548 |
84 | EEF2K | 0.64774886 |
85 | MAPKAPK3 | 0.64229940 |
86 | FGFR3 | 0.64229736 |
87 | FRK | 0.62794283 |
88 | MAP3K3 | 0.62197966 |
89 | TAF1 | 0.62069367 |
90 | EPHA2 | 0.60693087 |
91 | TIE1 | 0.60210156 |
92 | EPHA3 | 0.58228804 |
93 | AURKB | 0.57407126 |
94 | RPS6KA5 | 0.56113728 |
95 | NUAK1 | 0.53901510 |
96 | MAP3K1 | 0.52809316 |
97 | ATR | 0.51742836 |
98 | CDK4 | 0.51245792 |
99 | TRIB3 | 0.50903703 |
100 | ZAK | 0.50247698 |
101 | MARK3 | 0.49854390 |
102 | IRAK1 | 0.48949724 |
103 | PAK1 | 0.48705601 |
104 | BCKDK | 0.48560219 |
105 | ABL2 | 0.48494270 |
106 | ARAF | 0.48178470 |
107 | TRPM7 | 0.47717589 |
108 | MAPKAPK2 | 0.46793506 |
109 | DYRK3 | 0.46664369 |
110 | PTK6 | 0.46210108 |
111 | HIPK2 | 0.45933208 |
112 | CDK7 | 0.45758174 |
113 | CDC7 | 0.45599436 |
114 | MAP2K2 | 0.45371260 |
115 | PRKCQ | 0.45137032 |
116 | RAF1 | 0.45112849 |
117 | JAK2 | 0.44084758 |
118 | PRKCD | 0.42642582 |
119 | PLK1 | 0.41565489 |
120 | CDK8 | 0.39441316 |
121 | PDK1 | 0.38478229 |
122 | BMX | 0.37891460 |
123 | ILK | 0.37354356 |
124 | GRK7 | 0.37178987 |
125 | MAPK11 | 0.36156795 |
126 | PTK2B | 0.35978178 |
127 | PRKG2 | 0.35589479 |
128 | NEK1 | 0.35577971 |
129 | GRK5 | 0.33564830 |
130 | MYLK | 0.33140420 |
131 | PDK2 | 0.31886024 |
132 | CSNK2A1 | 0.31848886 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.73747419 |
2 | Proteasome_Homo sapiens_hsa03050 | 2.60574624 |
3 | Ribosome_Homo sapiens_hsa03010 | 2.45765901 |
4 | DNA replication_Homo sapiens_hsa03030 | 2.29880790 |
5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.09344253 |
6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.07090093 |
7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.99646183 |
8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.95274658 |
9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.89775531 |
10 | Allograft rejection_Homo sapiens_hsa05330 | 1.81295285 |
11 | Leishmaniasis_Homo sapiens_hsa05140 | 1.79527257 |
12 | Measles_Homo sapiens_hsa05162 | 1.76088005 |
13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.73490671 |
14 | Mismatch repair_Homo sapiens_hsa03430 | 1.67499578 |
15 | Base excision repair_Homo sapiens_hsa03410 | 1.65538103 |
16 | Legionellosis_Homo sapiens_hsa05134 | 1.55497525 |
17 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.53415141 |
18 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.51525401 |
19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.47228534 |
20 | Spliceosome_Homo sapiens_hsa03040 | 1.45178655 |
21 | Protein export_Homo sapiens_hsa03060 | 1.37826713 |
22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.37037375 |
23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.33994732 |
24 | Homologous recombination_Homo sapiens_hsa03440 | 1.32760775 |
25 | Platelet activation_Homo sapiens_hsa04611 | 1.28992200 |
26 | RNA polymerase_Homo sapiens_hsa03020 | 1.27886676 |
27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.24560779 |
28 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.22593828 |
29 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.21855703 |
30 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.19435206 |
31 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.18369863 |
32 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.17362652 |
33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.16949361 |
34 | Other glycan degradation_Homo sapiens_hsa00511 | 1.12473092 |
35 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.09019785 |
36 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.08702962 |
37 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.08254103 |
38 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.07069695 |
39 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.06577576 |
40 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.06082339 |
41 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.04753218 |
42 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.04542647 |
43 | Shigellosis_Homo sapiens_hsa05131 | 1.04365336 |
44 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.03657167 |
45 | Sulfur relay system_Homo sapiens_hsa04122 | 1.03253615 |
46 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.02577397 |
47 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.02479350 |
48 | Apoptosis_Homo sapiens_hsa04210 | 0.99878498 |
49 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.99690392 |
50 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.95925479 |
51 | Malaria_Homo sapiens_hsa05144 | 0.95412435 |
52 | Influenza A_Homo sapiens_hsa05164 | 0.94784131 |
53 | Pertussis_Homo sapiens_hsa05133 | 0.93909065 |
54 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.93164098 |
55 | Phagosome_Homo sapiens_hsa04145 | 0.90715667 |
56 | Cell cycle_Homo sapiens_hsa04110 | 0.89964511 |
57 | RNA transport_Homo sapiens_hsa03013 | 0.89620903 |
58 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.89604332 |
59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.87465621 |
60 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.85668091 |
61 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.85344529 |
62 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.85154051 |
63 | Viral myocarditis_Homo sapiens_hsa05416 | 0.83628649 |
64 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.82507905 |
65 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.80563828 |
66 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.80202767 |
67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.76661099 |
68 | Hepatitis B_Homo sapiens_hsa05161 | 0.75888481 |
69 | Asthma_Homo sapiens_hsa05310 | 0.75283976 |
70 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.73217580 |
71 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.73047091 |
72 | Tuberculosis_Homo sapiens_hsa05152 | 0.72009081 |
73 | Lysosome_Homo sapiens_hsa04142 | 0.71596612 |
74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.71332709 |
75 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.65616722 |
76 | RNA degradation_Homo sapiens_hsa03018 | 0.64941058 |
77 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64803493 |
78 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64752456 |
79 | Hepatitis C_Homo sapiens_hsa05160 | 0.63742266 |
80 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.61881728 |
81 | Histidine metabolism_Homo sapiens_hsa00340 | 0.61446995 |
82 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.60294667 |
83 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.60058620 |
84 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.59775929 |
85 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.59345589 |
86 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.58343410 |
87 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.56551308 |
88 | HTLV-I infection_Homo sapiens_hsa05166 | 0.55731408 |
89 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.55718583 |
90 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.55713166 |
91 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55623638 |
92 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55522822 |
93 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.55154319 |
94 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.54158836 |
95 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.53852847 |
96 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.53324826 |
97 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.52926905 |
98 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.52541663 |
99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51240868 |
100 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.51037507 |
101 | Salmonella infection_Homo sapiens_hsa05132 | 0.51011772 |
102 | Peroxisome_Homo sapiens_hsa04146 | 0.49115434 |
103 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.48966591 |
104 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48843465 |
105 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.48193242 |
106 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.47417158 |
107 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.47013340 |
108 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.46799703 |
109 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46393338 |
110 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.45743267 |
111 | Purine metabolism_Homo sapiens_hsa00230 | 0.42549900 |
112 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.42025647 |
113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41349018 |
114 | Parkinsons disease_Homo sapiens_hsa05012 | 0.37674961 |
115 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.37181648 |
116 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34476263 |
117 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.33645914 |
118 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.31872995 |
119 | * Endocytosis_Homo sapiens_hsa04144 | 0.30246956 |
120 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.29704439 |
121 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.25853894 |
122 | Bladder cancer_Homo sapiens_hsa05219 | 0.22432958 |